Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.
The item "Operating-Return-On-Assets" stands at 8.79 percent as of 06/30/2025, the lowest value since 03/31/2024.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Operating Return On Assets" stands at 8.79 Percent. This represents a decrease of -0.12 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.3627 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.3627.
The 3 year change in percentage points is 1.18.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Return On Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Return On Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Return On Assets | 280,205,508,085.11 |